'No Surprise' Says Vertex As NICE Fails To Recommend Orkambi In CF

Vertex Pharmaceuticals Inc. says it is "not surprised" that NICE has issued draft guidance not recommending Orkambi (lumacaftor/ivacaftor) for use on the NHS in England.